Literature DB >> 21288

Specific labeling of intracellular Toxoplasma gondii with uracil.

E R Pfefferkorn, L C Pfefferkorn.   

Abstract

Radioactive uracil was not significantly incorporated into the nucleic acids of human fibroblast cells. Infection of these cells with Toxoplasma gondii resulted in an exponential increase in the rate of uracil incorporation that paralleled the exponential growth of the parasite. One day after infection the rate of uracil incorporation was increased 100-fold. It was established by autoradiography that all of the [3H] uracil was incorporated into the intracellular parasites. A possible explanation for this difference in ability to use uracil is our observation that the specific activity of uridine phosphorylase was 100-fold greater in partially purified parasites than in the host cell.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 21288     DOI: 10.1111/j.1550-7408.1977.tb04774.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  63 in total

1.  Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation.

Authors:  Y W Zhang; K Kim; Y F Ma; M Wittner; H B Tanowitz; L M Weiss
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

2.  High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein.

Authors:  Marc-Jan Gubbels; Catherine Li; Boris Striepen
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  Activity of the histone deacetylase inhibitor FR235222 on Toxoplasma gondii: inhibition of stage conversion of the parasite cyst form and study of new derivative compounds.

Authors:  Danièle Maubon; Alexandre Bougdour; Yung-Sing Wong; Marie-Pierre Brenier-Pinchart; Aurélie Curt; Mohamed-Ali Hakimi; Hervé Pelloux
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

4.  Overexpression of a cytosolic pyrophosphatase (TgPPase) reveals a regulatory role of PP(i) in glycolysis for Toxoplasma gondii.

Authors:  Douglas A Pace; Jianmin Fang; Roxana Cintron; Melissa D Docampo; Silvia N J Moreno
Journal:  Biochem J       Date:  2011-12-01       Impact factor: 3.857

5.  Cell surface heparan sulfate promotes replication of Toxoplasma gondii.

Authors:  Joseph R Bishop; Brett E Crawford; Jeffrey D Esko
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 6.  Biochemistry of Plasmodium (malarial parasites).

Authors:  I W Sherman
Journal:  Microbiol Rev       Date:  1979-12

7.  Ligands of the peripheral benzodiazepine receptor are potent inhibitors of Plasmodium falciparum and Toxoplasma gondii in vitro.

Authors:  Florence Dzierszinski; Alexandra Coppin; Marlene Mortuaire; Etienne Dewailly; Christian Slomianny; Jean-Claude Ameisen; Frederic DeBels; Stanislas Tomavo
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

8.  Targeted disruption of the GRA2 locus in Toxoplasma gondii decreases acute virulence in mice.

Authors:  C Mercier; D K Howe; D Mordue; M Lingnau; L D Sibley
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy.

Authors:  L D Sibley; M Messina; I R Niesman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

10.  UNC93B1 mediates host resistance to infection with Toxoplasma gondii.

Authors:  Mariane B Melo; Pia Kasperkovitz; Anna Cerny; Stephanie Könen-Waisman; Evelyn A Kurt-Jones; Egil Lien; Bruce Beutler; Jonathan C Howard; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.